PT  - JOURNAL ARTICLE
AU  - Giovanna Ferrara
AU  - Serena Pastore
AU  - Lara Sancin
AU  - Lucio Torelli
AU  - Oriano Radillo
AU  - Matteo Bramuzzo
AU  - Chiara Bibalo
AU  - Alberto Tommasini
AU  - Alessandro Ventura
AU  - Andrea Taddio
TI  - Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis
AID  - 10.3899/jrheum.171200
DP  - 2018 Oct 01
TA  - The Journal of Rheumatology
PG  - 1418--1421
VI  - 45
IP  - 10
4099  - http://www.jrheum.org/content/45/10/1418.short
4100  - http://www.jrheum.org/content/45/10/1418.full
SO  - J Rheumatol2018 Oct 01; 45
AB  - Objective. This study aimed to test fecal calprotectin (FC) as a screening tool to identify inflammatory bowel disease (IBD) among patients with juvenile idiopathic arthritis (JIA).Methods. FC level < 100 g/kg was considered normal. Patients with 2 consecutive FC dosage ≥ 100 g/kg underwent endoscopic evaluation.Results. There were 113 patients with JIA enrolled. FC was raised in 7 patients out of 113. All patients had IBD. In 3/7 patients, high FC levels were the only sign consistent with IBD.Conclusion. FC is a useful, economical, and noninvasive diagnostic tool to identify JIA patients with underlying IBD.